Although the case-control or the cross-sectional design has been popular in genetic association studies of human longevity, such a design is prone to false positive results due to sampling bias and potential secular trend in gene-environment interactions. In order to avoid these problems, the cohort or follow-up study design has been recommended. With the observed individual survival information, the Cox regression model has been used for single locus data analysis. In this paper, we present a novel survival analysis model that combines population survival with individual genotype and phenotype information in assessing the genetic association with human longevity in cohort studies. By monitoring the changes in the observed genotype frequencies over the follow-up period in a birth cohort, we are able to assess the effects of the genotypes and /or haplotypes on individual survival. With the estimated parameters, genotype and/or haplotype specific survival and hazard functions can be calculated without any parametric assumption on the survival distribution. In addition, our model estimates haplotype frequencies in a birth cohort over the follow-up time, which is not observable in the multi-locus genotype data. A computer simulation study was conducted to specifically assess the performance and power of our haplotype based approach for given risk and frequency parameters under different sample sizes.
Introduction
The current genetic association study on human aging and longevity is dominated by the case-control (cases represent long-lived and controls the younger aged) or cross-sectional design. In these studies, subjects of different ages are genotyped, and frequencies of a particular gene variant are compared across the observed ages to infer genetic association . In term of analytical methods, new statistical approaches have been proposed to help analyzing genotype data collected in cross-sectional studies with improved power (TAN et al. 2004 ). Lewis and Brunner (2004) explored the validity of the basic assumptions in the crosssectional approach, i.e. no secular change in both risk and initial frequency of the gene under study.
Their study concluded that the assumptions are questionable when gene frequency differs in populations and gene-environment interactions exist and suggested conducting long-term follow-up studies to ensure verifiable results. Although the cohort study design is expensive due to the long term of follow-up, it is practically affordable to carry out follow-up studies on aged subjects given the high mortality rate at advanced ages. In this case, the study aims at investigating the genetic effect on human survival at extreme ages, an important topic nowadays because of the largely increased mean lifespan in the developed countries (VAUPEL et al. 1998) . In the literature, association studies using follow-up design on oldest-old subjects such as nonagenarians (CHRISTIANSEN et al. 2004; HURME et al. 2005) and centenarians (BLANCHE et al. 2001; LOUHIJA et al. 2001) have already been conducted. With the collected genotype and survival information, traditional statistical methods have been employed for single locus analysis, for example, frequency comparison using simple χ 2 (trend) test or estimating genotype relative risk using the traditional Cox regression model.
In the context of human disease gene mapping, multi-locus approaches such as the haplotype based association analysis have been introduced (SCHAID et al. 2002; ZHAO et al. 2003) . Haplotype based analysis exhibits more power due to its functional and statistical advantages over the single locus approach in linkage disequilibrium mapping (AKEY et al. 2001; SCHAID, 2004; CLARK, 2004) . Unfortunately, haplotype analysis in population-based human longevity studies encounters the problem of missing phases in the long-lived subjects because genotype information is unavailable from their parents. We present a novel survival analysis model that combines population survival with individual genotype and phenotype information in assessing the genetic association with human longevity in cohort studies. By monitoring the changes in the observed genotype frequencies over the follow-up period in a birth cohort, we are able to assess the effects of the genotypes and /or haplotypes on individual survival. With the estimated parameters, genotype and/or haplotype specific survival and hazard functions can be calculated without any parametric assumption on the survival distribution. In addition, our model estimates haplotype frequencies in a birth cohort over the follow-up time, which is not observable in the multi-locus genotype data. A computer simulation study was conducted to evaluate the performance of our model. For given haplotype risk and frequency parameters, we assess the power of our model under different sample sizes and years of follow-up. The model is applied to measure the association of paraoxonase 1 (PON1) gene polymorphism with human survival at advanced ages in the Danish 1905 birth cohort followed from 1998 to 2005. Application of our model helped us to detect a haplotype of PON1 gene that significantly reduces the carrier's hazard of death over the follow-up.
Methods

The basic model for genotype based analysis
We suppose that we start our follow-up study in a birth cohort of old subjects from initial age 0 x . For each individual, we obtain genotype information at a biallelic locus (e.g. a SNP locus) for assessing its influence on conditional survival after age 0 x . Combination of the two alleles (1 and 2) forms three genotypes (11, 12 and 22 
In order to take into account the effects of unobserved risk factors (both genetic and non-genetic), the frailty model (VAUPEL et al. 1979) 
By introducing (4) or (5) into (2) and based on the multinomial distribution of the proportions of genotype carriers at age x (from 0 x to t x + 0 ) in the birth cohort, we construct the likelihood function to estimate the genotype risk and frequency parameters, In the estimation, a parametric form of the baseline hazard function can be assigned. However, by introducing the mean cohort survival available from population statistics into (1), a non-parametric baseline hazard function can be estimated. This is done using a two-step procedure (YASHIN et al. 1999; TAN et al. 2001 ) in which we start with an initial guess of the risk and frequency parameters and then numerically solve (1) to obtain a non-parametric baseline hazard function. This hazard function is introduced into (6) to estimate the risk and frequency parameters. The estimated parameters are put back into (1) to calculate an updated baseline hazard function. This process continues until the likelihood converges .
The extended model for haplotype based analysis
When genotypes at closely linked loci are available, haplotype based analysis can be performed. Different from genotypes that are observable for each individual, individual haplotypes can not be determined explicitly without knowing phases. We start with assuming that all the haplotypes occurring at the typed loci are unambiguously observed and denote the collection of them with H . Under Hardy-Weinberg equilibrium (HWE), the frequency of the haplotype pair
where i p and j p are the haplotype frequencies at initial age 0 x for haplotypes i h and j h . We further assume that the relative risk on hazard of death for carriers of haplotype i h is r . For carriers of haplotype i h , the hazard of death at follow-up age x is )
in a proportional hazard model. Similar to the situation of genotype based analysis, both homogeneity (no unobserved risk factor) and heterogeneity or frailty models can be fitted. In any case, the mean conditional survival of the birth cohort is the weighted survival for carriers of the different haplotype pairs, i.e.
Likewise, at age x , the frequency of carriers of haplotype pair ) , (
Up to now, the haplotype-based parameterization is made by assuming that haplotypes are known explicitly for each individual.
In practice, what we observe are unphased multi-locus genotypes instead of haplotypes. However, for each multi-locus genotype g , we have a set of haplotype pairs denoted as ) (g S , that are consistent with g . With this relationship, we can express the frequency of the multi-locus genotype g at follow-up age x in the birth cohort as,
Based on the multinomial distribution of the multi-locus genotype frequencies in the birth cohort,
we construct the likelihood function for estimating the haplotype risk and frequency parameters,
where ) (x n g is the number of carriers of the multi-locus genotype g at follow-up age x . Similar to the genotype-based analysis, a constraint is imposed in the estimation procedure such that frequencies of all haplotypes sum up to 1. The likelihood function is maximized using the two-step procedure similar to that in the genotype based analysis but with haplotype based parameterizations.
With the maximum likelihood estimates, we are able to calculate the frequency trajectory for haplotype i h over the follow-up ages as
In the haplotype based analyses, non-carriers of the haplotype serve as the references to ensure that the model is identifiable. In the maximum likelihood estimation, the covariance matrix obtained by inversing the information matrix can be used to calculate the univariate Wald statistics for significance inferences of the risk parameters and for constructing the confidence intervals for the estimated relative risks of the haplotypes.
All computer codes written in the GAUSS programming language are freely available upon contacting the corresponding author.
Simulation study
In order to examine the validity of our model, we conducted a computer simulation study specifically on our haplotype based analysis. In the simulation, we assign different haplotype relative risks (a modest risk of 0.8 and a strong risk of 0.6) for a three-locus haplotype. Also we assign different sample sizes (500 and 1,000) for the birth cohort starting from the initial follow-up age of 93. Power of our model is assessed for samples collected from 3, 5 and 7 years of follow-up.
For each setting, we calculate the power as the probability that the 95% confidence limit of the In Table 1 , we show the results from our simulation study using 1,000 replicates. We can see that, overall, our model produces unbiased estimates for the fixed haplotype risk and frequency parameters used in generating the multi-locus genotype data. The precision of the estimated relative risks as indicated by their percentiles goes up with increasing sample sizes and extending follow-up time. Interestingly, the precision in haplotype frequency estimation is only affected by the sample size but not the length of follow-up. This is sensible because the initial haplotype frequency is the frequency at the beginning of the follow-up when everybody in the cohort was alive. The upper part of indicate that, for both N=500 and 1,000, an approximate follow-up of 5 years is required to achieve an acceptable power. Overall, a short period of follow-up time (3 years) does not lead to sufficient power in the analysis except for a strong effect haplotype ( 6 . 0 = r ) with a frequency of above ten percent in a large scale study (N=1,000).
Finally, a large birth cohort of 10,000 individuals (over 93 years) was simulated. This time we assume that there is a harmful haplotype that increases carrier's hazard of death with a relative risk of 1.5 and frequency of the haplotype at the initial age is chosen as 0.284. In Figure 1, we show the theoretical, the simulated and the estimated frequency trajectories for the haplotype after 7 years follow-up. Both the theoretical (solid line) and the simulated (dashed line) frequency patterns are well captured by our model (the dash-dotted line). Note also that all three lines start from the initial frequency we set in the simulation.
Example application
Previous studies have shown that the antioxidant enzyme paraoxonase 1 (PON1) is associated with susceptibility to cardiovascular disorders (HEINECKE and LUSIS, 1998; WATSON et al. 1995) . Recently, PON1 gene polymorphisms have been found to affect human survival (BONAFE et al. 2002; CHRISTIANSEN et al. 2004 ). In the study by Christiansen et al. (2004) , three SNPs in the PON1 gene (two in the coding region, amino acids M55L and Q192R, and one in the promoter region, C-107T) were genotyped. Data analysis using the Cox regression model revealed a strong protective effect of the 55M/L genotype and an increased risk of death for carriers of 192R/R genotype in females (a relative risk of 1.38). In their study, haplotype analysis was not possible because such an analysis is not supported by the traditional Cox regression model.
In this example application, we apply our model to a sub-sample in their study, the female 1905 cohort data, and perform both genotype and haplotype based analyses. Since the start of the followup at the initial age of 93 years, survival information has been collected for a period of 6 years. The cohort survival function is taken from the female life table of the Danish 1905 cohort (http://www.mortality.org). Similar to the simulation study, we introduce a gamma-distributed frailty model (mean 1, variance 0.1) in our analysis to take into account the influence on survival from the unobserved factors.
In Table 2 , we show the genotype counts and number of typed individuals at the three loci. Chi-squared tests on each locus showed that all three loci are in Hardy-Weinberg equilibrium at PON1 Q192R). We present our results on genotype based analysis in Table 2 where, as described in the methods section, risk and frequency parameters are estimated for each genotype against the reference. Although only a sub-sample was used, our model detected PON1 192 Q/Q and Q/R genotypes as of potential influence (p=0.062 for Q/R and p=0.076 for Q/Q genotypes), a result consistent with Christiansen et al. (2004) . In Figure 2 , we show the observed and the estimated genotype frequency patterns for all genotypes at the three loci.
Based on genotype information from the three loci, we carried out a haplotype based analysis using our extended model. By taking individuals with genotype information available at all three loci, we obtained a sample size of 451 for haplotype analysis. We first tested the linkage disequilibrium between the markers using GENECOUNTING software (ZHAO et al. 2002) . Very strong marker-marker disequilibrium was found between markers C-107T and M55L ( 
Discussion
Recent association studies are increasingly emphasizing the important roles that genes may play in affecting human survival at advanced ages (BONAFE et al. 2002; CHRISTIANSEN et al. 2004; HURME et al. 2005; BELLIZZI et al. 2005) . Further studies using efficient analytical tools are needed. Through computer simulation and model application, we have shown that our survival analysis model is a valid method for both genotype and haplotype based association analyses of human survival in cohort studies of elderly subjects. Our computer simulation approach not only validates our model but also provides important information useful in planning future researches. In addition, empirical application of the model to our PON1 genotype data has helped us to identify an important haplotype that favors human longevity and indicates an increased power of the haplotype model.
Although our model can support the parametric form of the baseline hazard function,
it is important to point out that, by incorporating the cohort specific survival function available from population statistics, our model conducts parameter estimation without imposing any parametric form of the hazard function. This means that our model provides a non-parametric approach in analyzing survival data at advanced ages. This is important because, at extreme ages, validity of the parametric survival functions, such as the Gompertz or the Gompertz-Makeham models, has been seriously questioned (DRIVER, 2001) . In addition, when the sample size is limited at advanced ages, there will be a considerable error in estimating the survival distribution which consequently leads to unreliable results. Since our model models the genotype or haplotype frequency patterns in the survivors over the follow-up period, with the estimated parameters, the fitted frequency trajectory over the observed period can be examined (Figures 2 and 3) for each genotype or haplotype. This is especially useful in haplotype based analysis because, unlike the single locus analysis, we do not actually observe the individual haplotype in population studies. Moreover, since the parameters are estimated by monitoring the genotype or haplotype frequencies in the survivors over the follow-up period in a birth cohort, exact individual lifespan is not necessarily required to apply the model. This means that censoring is not a problem at all in our analysis. Finally, although the method is introduced using SNP markers, extending to multi-allelic loci only involves more genotypes or haplotypes in the analysis.
Here, we emphasize the importance of the frailty modeling in our analysis. It is well known that, at advanced ages, the cause specific mortality curves start to converge as a result of heterogeneity in individual's frailty composition (VAUPEL et al. 1998) . As a result, ignoring the existence of the competing risk factors can substantially underestimate the risks of genotypes or haplotypes. Frailty modeling in our genotype and haplotype based analyses can help us to assess the risk parameters in a more realistic manner. Most importantly, since haplotype analysis is biologically as well as statistically advantageous over the single locus approach, our haplotype model with frailty modeling provides a powerful method in data analysis. In addition, we point out that the applicability of our model is theoretically not limited to longevity studies. Application of our model to any time to event data, for example, the age of onset of a disease, is feasible provided that the population probability distribution of the time to onset of the disease is available.
Based on the mixed results from conducted follow-up studies on apolipoprotein E gene and longevity, Lewis and Brunner (2004) suggested that adequate cohort studies with longer follow-up (above 5 years) be conducted in order to obtain reliable results. It is interesting to see from Table 1 that their conclusion seems to comply with our simulation. Since the cohort design avoids the validity issues concerning a cross-sectional design (secular change in the risk and initial frequency of the observed gene), our simulation result is promising because, with a proper analytical approach, effect of a gene on human extreme age survival can be detected within an 
Following the traditional approach (VAUPEL et al. 1979; HOUGAARD, 1991; AALEN, 1998) , we assume that the frailty z is gamma-distributed with mean 1 and variance
can be derived as YASHIN et al. 2000; TAN et al. 2001) . Based on our experiences in fitting the gamma-frailty model to large population data sets, one can alternatively fit a frailty model by simply setting 2 σ to 0.1. This can be conservative compared with some empirical results (YASHIN et al. 2000; TAN et al. 2001; EWBANK, 2002) . However, we think it is applicable for small data sets. 
